50242-0087
Kadcyla
ADO-Trastuzumab Emtansine
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Intravenous
ADO-Trastuzumab Emtansine
20.0
mg/mL

TRASTUZUMAB EMTANSINE
20.0
mg/mL
50242-0087-01
1 VIAL, SINGLE-USE in 1 CARTON (50242-087-01) > 8 mL in 1 VIAL, SINGLE-USE
Feb. 22, 2013
Immunotherapy
Drug Antibody Conjugate
HER2
 
In Use